These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 7031982)
1. In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. I. Effects of heparin fractions. Schmitz-Huebner U; Balleisen L; Asbeck F; van de Loo J Thromb Haemost; 1981 Oct; 46(3):612-6. PubMed ID: 7031982 [TBL] [Abstract][Full Text] [Related]
2. In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. II. Effects of a heparin analogue. Schmitz-Huebner U; Asbeck F; van de Loo J Thromb Haemost; 1981 Oct; 46(3):617-20. PubMed ID: 6797091 [TBL] [Abstract][Full Text] [Related]
3. Dose response relationships of anticoagulant activities after subcutaneous administration of two low molecular weight heparins in healthy individuals. Hellstern P; Kiehl R; von Blohn G; Köhler M; Meierhenrich U; Wenzel E Thromb Haemost; 1986 Oct; 56(2):225-8. PubMed ID: 3810557 [TBL] [Abstract][Full Text] [Related]
4. Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteers. Harenberg J; Giese C; Dempfle CE; Stehle G; Heene DL Thromb Haemost; 1989 Jun; 61(3):357-62. PubMed ID: 2552604 [TBL] [Abstract][Full Text] [Related]
5. Studies in man and experimental animals of a low molecular weight heparin fraction. Thomas DP; Merton RE; Lewis WE; Barrowcliffe TW Thromb Haemost; 1981 Jun; 45(3):214-8. PubMed ID: 7281101 [TBL] [Abstract][Full Text] [Related]
6. Comparison of low molecular weight heparins and unfractionated heparin after successive subcutaneous administration. A randomized controlled study in healthy volunteers. Pindur G; Heiden M; Köhler M Arzneimittelforschung; 1993 May; 43(5):542-7. PubMed ID: 8392345 [TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins. Harenberg J J Mal Vasc; 1987; 12 Suppl B():68-70. PubMed ID: 2834495 [TBL] [Abstract][Full Text] [Related]
8. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo. Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450 [TBL] [Abstract][Full Text] [Related]
9. [Effect of low-molecular heparin on blood coagulation]. Harenberg J; de Vries JX; Weber E; Zimmermann R Dtsch Med Wochenschr; 1984 Jun; 109(24):951-4. PubMed ID: 6734448 [TBL] [Abstract][Full Text] [Related]
10. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf. Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835 [TBL] [Abstract][Full Text] [Related]
11. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects. Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174 [TBL] [Abstract][Full Text] [Related]
12. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man. Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826 [TBL] [Abstract][Full Text] [Related]
13. [Effect of unfractionated and low-molecular-weight heparin on platelet aggregation and in vitro bleeding time in dogs]. Nimmerfall K; Mischke R Dtsch Tierarztl Wochenschr; 1999 Oct; 106(10):439-44. PubMed ID: 10589154 [TBL] [Abstract][Full Text] [Related]
14. The effect of subcutaneous injection of unfractionated and low molecular weight heparin on thrombin generation in platelet rich plasma--a study in human volunteers. Bendetowicz AV; Kai H; Knebel R; Caplain H; Hemker HC; Lindhout T; Béguin S Thromb Haemost; 1994 Nov; 72(5):705-12. PubMed ID: 7900078 [TBL] [Abstract][Full Text] [Related]
15. Influence of low molecular weight heparin on the hemostatic system after abdominal surgery. Schmitz-Huebner U; Rüschemeyer C; Schulte H; van de Loo J Thromb Haemost; 1985 Jun; 53(3):297-300. PubMed ID: 3901387 [TBL] [Abstract][Full Text] [Related]
16. [Effect of a high single subcutaneous dose of unfractionated heparin on platelet function in dogs]. Mischke R; Nimmerfall K Berl Munch Tierarztl Wochenschr; 2000 Feb; 113(2):60-4. PubMed ID: 10726363 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of a low molecular weight heparin (enoxaparin) after subcutaneous injection, comparison with unfractionated heparin--a three way cross over study in human volunteers. Bendetowicz AV; Béguin S; Caplain H; Hemker HC Thromb Haemost; 1994 Mar; 71(3):305-13. PubMed ID: 8029794 [TBL] [Abstract][Full Text] [Related]
18. Chrono-pharmacological study of once daily curative dose of a low molecular weight heparin (200 IU antiXa/kg of Dalteparin) in ten healthy volunteers. Mismetti P; Reynaud J; Tardy-Ponce B; Laporte-Simitsidis S; Scully M; Goodwyn C; Queneau P; Decousus H Thromb Haemost; 1995 Aug; 74(2):660-6. PubMed ID: 8585003 [TBL] [Abstract][Full Text] [Related]
19. Effects of a heparin-binding protein on blood coagulation and platelet function. Kaiser P; Harenberg J; Walenga JM; Huhle G; Giese C; Prechel M; Hoppensteadt D; Fareed J Semin Thromb Hemost; 2001 Oct; 27(5):495-502. PubMed ID: 11668419 [TBL] [Abstract][Full Text] [Related]